ATE251447T1 - Pharmazeutische zubereitungen zur inhalation eines opioids - Google Patents

Pharmazeutische zubereitungen zur inhalation eines opioids

Info

Publication number
ATE251447T1
ATE251447T1 AT98962686T AT98962686T ATE251447T1 AT E251447 T1 ATE251447 T1 AT E251447T1 AT 98962686 T AT98962686 T AT 98962686T AT 98962686 T AT98962686 T AT 98962686T AT E251447 T1 ATE251447 T1 AT E251447T1
Authority
AT
Austria
Prior art keywords
opioids
dry powder
inhalation
administered
opioid
Prior art date
Application number
AT98962686T
Other languages
English (en)
Inventor
Volcmar Verkerk
Marianne Elisabeth Blom-Ross
Dort Karin Van
Vos Dick De
Original Assignee
Pharmachemie Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv
Application granted granted Critical
Publication of ATE251447T1 publication Critical patent/ATE251447T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AT98962686T 1998-12-11 1998-12-11 Pharmazeutische zubereitungen zur inhalation eines opioids ATE251447T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL1998/000713 WO2000035417A1 (en) 1998-12-11 1998-12-11 Pharmaceutical preparation for inhalation of an opioid

Publications (1)

Publication Number Publication Date
ATE251447T1 true ATE251447T1 (de) 2003-10-15

Family

ID=19866466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98962686T ATE251447T1 (de) 1998-12-11 1998-12-11 Pharmazeutische zubereitungen zur inhalation eines opioids

Country Status (11)

Country Link
US (1) US20010041164A1 (de)
EP (1) EP1137398B1 (de)
JP (1) JP2002532405A (de)
AT (1) ATE251447T1 (de)
AU (1) AU1786199A (de)
CA (1) CA2354576C (de)
DE (1) DE69818872T2 (de)
DK (1) DK1137398T3 (de)
ES (1) ES2207867T3 (de)
IL (2) IL143576A0 (de)
WO (1) WO2000035417A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737042B2 (en) 2001-05-24 2004-05-18 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
DK1389096T3 (da) * 2001-05-24 2009-06-22 Alexza Pharmaceuticals Inc Indgivelse af opiater gennem en inhalationsrute
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
ATE520405T1 (de) * 2002-08-21 2011-09-15 Norton Healthcare Ltd Inhalationszusammensetzung
GB0219513D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions including coarse carrier
EP1603533B1 (de) * 2003-02-28 2009-04-15 YM Biosciences Inc. Opioidabgabesystem
WO2004104490A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Self-contained heating unit and drug-supply unit employing same
WO2006124556A2 (en) * 2005-05-13 2006-11-23 Glaxo Group Limited Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
WO2008112661A2 (en) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US20100183687A1 (en) * 2009-01-22 2010-07-22 Cox D Phillip Process for preparing particles of opioids and compositions produced thereby

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
GB9103302D0 (en) * 1991-02-16 1991-04-03 Smithkline Beecham Plc Pharmaceutical formulations
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation

Also Published As

Publication number Publication date
IL143576A0 (en) 2002-04-21
JP2002532405A (ja) 2002-10-02
ES2207867T3 (es) 2004-06-01
US20010041164A1 (en) 2001-11-15
EP1137398B1 (de) 2003-10-08
CA2354576C (en) 2008-10-14
IL143576A (en) 2006-10-31
AU1786199A (en) 2000-07-03
EP1137398A1 (de) 2001-10-04
DE69818872D1 (de) 2003-11-13
CA2354576A1 (en) 2000-06-22
DK1137398T3 (da) 2004-02-02
WO2000035417A1 (en) 2000-06-22
DE69818872T2 (de) 2004-05-19

Similar Documents

Publication Publication Date Title
CA2146954A1 (en) Breath activated nicotine inhalers
EE03221B1 (et) Inhaleeritavad ravimpreparaadid, nende valmistamise protsess ja inhalaator nende kasutamiseks
DK1019021T4 (da) Stabiliserede præparater til anvendelse i inhalatorer med afmålt dosis
EA200100338A1 (ru) Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента
ATE250922T1 (de) Verfahren und vorrichtung zur inhalation teilchenförmiger medikamente
EP3423058A1 (de) Nikotinformulierung und aerosole
DE69921785D1 (de) Nikotininhalator
TW200607538A (en) Medicament inhaler device
TNSN04149A1 (en) Pressurised metered dose inhalers containing solutions of beta-2 agonists
ATE251447T1 (de) Pharmazeutische zubereitungen zur inhalation eines opioids
Newman et al. The nasal distribution of metered does inhalers
BR0011343A (pt) Dispositivo de distribuição de medicamento,e,métodos de administrar um medicamento por inalação,e de,tratamento de um paciente com distúrbio respiratório
JP2001527442A (ja) ハロセラピーの投与方法
Calvert et al. Enhanced delivery of nebulised salbutamol during non‐invasive ventilation
HOFMANN et al. Aerosolized amiloride: dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis
NO20021681L (no) Anordning for avlevering av medikament, med fuktighetsbestandig belegg
US11006661B2 (en) Cigarette-like device for administration of substances
Everard et al. In vitro assessment of drug delivery through an endotracheal tube using a dry powder inhaler delivery system.
Silkstone et al. Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser
WO1997047344A1 (en) Method and device for facilitating the use of medical apparatus by patients
EP1110547A3 (de) Helium und Neon als Hilfsstoffe zur Wirkstoffverabreichung mittels Inhalator
BRPI0408059A (pt) sistema de administração de opióides
Steed et al. The oropharyngeal and lung deposition patterns of a fusafungine MDI spray delivered by HFA 134a propellant or by CFC 12 propellant
Coleman et al. Aerosol characteristics of 99mTc-pentetic acid (DTPA) and synthetic surfactant (Exosurf)
RU2012363C1 (ru) Устройство в.а.старцева для насыщения воздуха лекарственными веществами

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1137398

Country of ref document: EP

REN Ceased due to non-payment of the annual fee